Research Overview of S Citadep 10mg
S Citadep 10 mg Cipla is a selective serotonin reuptake inhibitor (SSRI) formulation containing escitalopram oxalate as the active pharmaceutical ingredient. This research-grade compound is manufactured by Cipla Limited, a leading pharmaceutical company known for quality pharmaceutical preparations. Escitalopram represents the S-enantiomer of citalopram, demonstrating enhanced selectivity for serotonin transporter inhibition in neurochemical research applications. Laboratory researchers investigating serotonergic neurotransmission pathways frequently examine this compound for its potent inhibitory effects on the serotonin reuptake transporter (SERT).
The pharmaceutical formulation offers researchers at Stroid UK Shop a standardised preparation for investigating selective serotonin reuptake mechanisms in controlled laboratory environments. Each tablet contains precisely 10mg of escitalopram oxalate, providing consistent dosing parameters for experimental protocols. Research applications include studies of neurotransmitter binding affinity, receptor selectivity investigations, and comparative analyses with other compounds available in our escitalopram research category. The compound’s high selectivity for SERT over other monoamine transporters makes it valuable for researchers examining specific serotonergic pathway modulation.
Laboratory Applications and Research Utility
Scientific investigations commonly employ S Citadep in neurochemistry research protocols examining serotonin transporter function, binding kinetics, and pharmacological selectivity profiles. Research teams analyse this compound’s interaction with various receptor subtypes, investigating its mechanism of action compared to other selective inhibitors. The pharmaceutical-grade preparation ensures consistent results across experimental replicates, supporting robust data collection in neuroscience research laboratories. Studies frequently examine the compound alongside materials from our SARMs collection when investigating receptor selectivity mechanisms. Comparative research protocols often evaluate escitalopram’s binding characteristics against other neurotransmitter modulators, including compounds from our peptides research range, providing comprehensive insights into selective targeting mechanisms.
Specification and Storage Parameters
| Parameter | Specification |
|---|---|
| Active Ingredient | Escitalopram Oxalate |
| Strength | 10mg per tablet |
| Manufacturer | Cipla Limited |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
| Form | Pharmaceutical tablets |
Research Compliance Statement
S Citadep 10mg Cipla is supplied exclusively for in-vitro research and laboratory analytical purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with local regulations governing research chemical handling and maintain appropriate laboratory safety protocols during investigation procedures.
